Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA
Sept 12 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA A/S - ON SEPT12, SUBMITTED A REQUEST FOR A
WRITTEN DECISION REGARDING PETITION FOR REVIEW REGARDING
EP2801355 TO THE EBA
* FORWARD PHARMA A/S - EXPECTS TO RECEIVE A WRITTEN
DECISION BY
THE END OF THE YEAR, WHICH IS EXPECTED TO CONCLUDE THE
OPPOSITION PROCEEDING
Source text for Eikon: ID: company coverage: FWP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA